{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:53:10Z","timestamp":1782435190150,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The purpose of this study is to evaluate the effectiveness of intensity-modulated radiation therapy (IMRT) combined with periorbital triamcinolone acetonide injection in treating thyroid eye disease (TED) patients with active extraocular muscle but low CAS. The retrospective observational study was conducted. A total of 156 eligible patients were selected from the TED patient database of the Ophthalmology Department of West China Hospital of Sichuan University. The patient\u2019s relevant medical history was recorded, including gender, age of initial onset, onset eye, the interval between onset and the first visit to our hospital, extraocular muscle condition, smoking status, CAS, NOSPECS, thyroid function, symptoms and signs, and the condition of the affected extraocular muscle. We found that IMRT combined with periorbital triamcinolone acetonide injection has a good therapeutic effect on TED patients with low CAS but significant active extraocular muscles, and there is a significant improvement at 3 months after treatment. Thyroid function and CAS can affect the curative effect of IMRT. Patients with hyperthyroidism had worse effect than those with normal thyroid function. The higher the CAS, the better the effect.<\/jats:p>","DOI":"10.1038\/s41598-025-88142-w","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T12:15:49Z","timestamp":1737807349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A curative effect evaluation of intensity-modulated radiation therapy combined with periorbital triamcinolone acetonide injection in treating thyroid eye disease patients with active extraocular muscle but low CAS"],"prefix":"10.1038","volume":"15","author":[{"given":"Hao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"key":"88142_CR1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"RS Bahn 2010 Graves\u2019 ophthalmopathy N. Engl. J. Med. 362 726 738 https:\/\/doi.org\/10.1056\/NEJMra0905750","journal-title":"N. Engl. J. Med."},{"key":"88142_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s40618-019-01141-3","volume":"43","author":"M Marin\u00f2","year":"2020","unstructured":"M Marin\u00f2  2020 Orbital diseases mimicking graves\u2019 orbitopathy: A long-standing challenge in differential diagnosis J. Endocrinol. Invest. 43 401 411 https:\/\/doi.org\/10.1007\/s40618-019-01141-3","journal-title":"J. Endocrinol. Invest."},{"key":"88142_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"L Bartalena  2016 The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy Guidelines for the Management of Graves\u2019 Orbitopathy Eur. Thyroid J. 5 9 26 https:\/\/doi.org\/10.1159\/000443828","journal-title":"Eur. Thyroid J."},{"key":"88142_CR4","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/eje-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"L Bartalena  2021 The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy Eur. J. Endocrinol. 185 G43 g67 https:\/\/doi.org\/10.1530\/eje-21-0479","journal-title":"Eur. J. Endocrinol."},{"key":"88142_CR5","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/s0002-9394(14)72787-4","volume":"119","author":"GB Bartley","year":"1995","unstructured":"GB Bartley CA Gorman 1995 Diagnostic criteria for Graves\u2019 ophthalmopathy Am. J. Ophthalmol. 119 792 795 https:\/\/doi.org\/10.1016\/s0002-9394(14)72787-4","journal-title":"Am. J. Ophthalmol."},{"key":"88142_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s004170050370","volume":"238","author":"S Tian","year":"2000","unstructured":"S Tian Y Nishida B Isberg G Lennerstrand 2000 MRI measurements of normal extraocular muscles and other orbital structures Graefe\u2019s Arch. Clin. Exp. Ophthalmol. Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 238 393 404 https:\/\/doi.org\/10.1007\/s004170050370","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol. Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"},{"key":"88142_CR7","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.26355\/eurrev_201904_17712","volume":"23","author":"L Zeng","year":"2019","unstructured":"L Zeng XQ Xie CH Li HS Shi F Wang 2019 Clinical study of the radiotherapy with EDGE accelerator in the treatment of the moderate and severe thyroid associated ophthalmopathy Eur. Rev. Med. Pharmacol. Sci. 23 3471 3477 https:\/\/doi.org\/10.26355\/eurrev_201904_17712","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"88142_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13014-017-0908-7","volume":"12","author":"YJ Li","year":"2017","unstructured":"YJ Li Y Luo WM He P Li F Wang 2017 Clinical outcomes of graves\u2019 ophthalmopathy treated with intensity modulated radiation therapy Radiat. Oncol. (London, England) 12 171 https:\/\/doi.org\/10.1186\/s13014-017-0908-7","journal-title":"Radiat. Oncol. (London, England)"},{"key":"88142_CR9","doi-asserted-by":"publisher","first-page":"249125","DOI":"10.1155\/2015\/249125","volume":"2015","author":"J Barrio-Barrio","year":"2015","unstructured":"J Barrio-Barrio AL Sabater E Bonet-Farriol \u00c1 Vel\u00e1zquez-Villoria JC Galofr\u00e9 2015 Graves\u2019 Ophthalmopathy: VISA VERSUS EUGOGO classification, assessment, and management J. Ophthalmol. 2015 249125 https:\/\/doi.org\/10.1155\/2015\/249125","journal-title":"J. Ophthalmol."},{"key":"88142_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1748-717x-7-95","volume":"7","author":"RS Prabhu","year":"2012","unstructured":"RS Prabhu  2012 Clinical outcomes of radiotherapy as initial local therapy for Graves\u2019 ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery Radiat. Oncol. (London, England) 7 95 https:\/\/doi.org\/10.1186\/1748-717x-7-95","journal-title":"Radiat. Oncol. (London, England)"},{"key":"88142_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2169\/internalmedicine.53.1518","volume":"53","author":"Y Hiromatsu","year":"2014","unstructured":"Y Hiromatsu H Eguchi J Tani M Kasaoka Y Teshima 2014 Graves\u2019 ophthalmopathy: Epidemiology and natural history Int. Med. (Tokyo, Japan) 53 353 360 https:\/\/doi.org\/10.2169\/internalmedicine.53.1518","journal-title":"Int. Med. (Tokyo, Japan)"},{"key":"88142_CR12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/bjo.73.8.639","volume":"73","author":"MP Mourits","year":"1989","unstructured":"MP Mourits  1989 Clinical criteria for the assessment of disease activity in Graves\u2019 ophthalmopathy: A novel approach Br. J. Ophthalmol. 73 639 644 https:\/\/doi.org\/10.1136\/bjo.73.8.639","journal-title":"Br. J. Ophthalmol."},{"key":"88142_CR13","first-page":"1932","volume":"70","author":"Y Hiromatsu","year":"2012","unstructured":"Y Hiromatsu H Eguchi J Tani 2012 Management of Graves\u2019 ophthalmopathy by using orbital magnetic resonance imaging Nihon Rinsho Jpn. J. Clin. Med. 70 1932 1937","journal-title":"Nihon Rinsho Jpn. J. Clin. Med."},{"key":"88142_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/197140091302600509","volume":"26","author":"F Tortora","year":"2013","unstructured":"F Tortora  2013 Disease activity in Graves\u2019 ophthalmopathy: Diagnosis with orbital MR imaging and correlation with clinical score Neuroradiol. J. 26 555 564 https:\/\/doi.org\/10.1177\/197140091302600509","journal-title":"Neuroradiol. J."},{"key":"88142_CR15","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1097\/iop.0000000000001139","volume":"34","author":"LC Siakallis","year":"2018","unstructured":"LC Siakallis JM Uddin KA Miszkiel 2018 Imaging investigation of thyroid eye disease Ophthal. Plastic Reconstr. Surg. 34 S41 s51 https:\/\/doi.org\/10.1097\/iop.0000000000001139","journal-title":"Ophthal. Plastic Reconstr. Surg."},{"key":"88142_CR16","doi-asserted-by":"publisher","first-page":"17834","DOI":"10.1038\/s41598-024-68809-6","volume":"14","author":"Q Han","year":"2024","unstructured":"Q Han X Mao S Tian 2024 A retrospective study on the effectiveness of intensity modulated radiation therapy for thyroid associated ophthalmopathy at a single institute Sci. Rep. 14 17834 https:\/\/doi.org\/10.1038\/s41598-024-68809-6","journal-title":"Sci. Rep."},{"key":"88142_CR17","doi-asserted-by":"publisher","first-page":"17533","DOI":"10.1038\/s41598-017-17893-y","volume":"7","author":"YJ Li","year":"2017","unstructured":"YJ Li  2017 The efficacy of intensity modulated radiation therapy in treating thyroid-associated ophthalmopathy and predictive factors for treatment response Sci. Rep. 7 17533 https:\/\/doi.org\/10.1038\/s41598-017-17893-y","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88142-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88142-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88142-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T12:15:52Z","timestamp":1737807352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88142-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88142"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88142-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]},"assertion":[{"value":"7 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3222"}}